Metabolic Surgery for Obese Type 2 Diabetes: Korean Multicenter Cohort Study - Takeaways - MDSpire

Metabolic Surgery for Obese Type 2 Diabetes: Korean Multicenter Cohort Study

  • By

  • Young Suk Park

  • Soo Min Ahn

  • Sang Hyun Kim

  • Sung Il Choi

  • Kyung Won Seo

  • Han Hong Lee

  • Youngsung Suh

  • Ji Yeon Park

  • Sang Eok Lee

  • Sungsoo Park

  • Dong Jin Kim

  • In Cho

  • Yoo Min Kim

  • Songchang Shi

  • Tae Jung Oh

  • Yun-Suhk Suh

  • Ki Hyun Kim

  • Seungwan Ryu

  • Mi Kyung Kim

  • Do Joong Park

  • Seong-Ho Kong

  • Young Min Cho

  • In Gyu Kwon

  • Jong Suk Park

  • Minyoung Lee

  • Hyuk-Joon Lee

  • November 13, 2025

  • 0 min

Share

  • 1

    Obesity and type 2 diabetes mellitus (T2DM) are significant global health challenges, with rising prevalence in East Asia, including Korea.

  • 2

    Metabolic/bariatric surgery (MBS) is an effective treatment for obesity and T2DM, recommended for patients with a BMI of 30 kg/m² or higher.

  • 3

    Sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) are the most common MBS procedures, each with distinct benefits and risks.

  • 4

    This study aims to compare the effects of SG and RYGB on glucose control and weight loss in Korean patients with obesity and T2DM.

  • 5

    The primary outcome is the rate of complete T2DM remission at 1 and 2 years postoperatively, with secondary outcomes including BMI changes and complications.

Original Source(s)

Related Content